Insight Conference
Research Fellow and Principal Investigator

Paul Liknaitzky, Ph.D.

Turner Institute (School of Psychological Sciences) and Dept of Psychiatry (School of Clinical Sciences), Monash University

Paul Liknaitzky works as a Research Fellow and Chief Principal Investigator at Monash University, and has adjunct or honorary appointments at St Vincent’s Hospital, Macquarie University, Deakin University, and the University of Melbourne. He earned an Honours in Neuroscience and a PhD in Psychology from the University of Melbourne. His work examines mechanisms of mental illness and treatment development primarily within mood disorder and addiction research. Dr. Liknaitzky is a Principal Investigator across a number of Australia’s first clinical psychedelic trials. He is currently establishing a rigorous program of research in psychedelic medicine at Monash University that seeks to evaluate therapeutic effects, innovate on treatment design, mitigate known risks, explore potential drawbacks, and understand therapeutic mechanisms.


A double-edged sword? Potential risks associated with key benefits of psychedelic treatments

Insight Newsletter

Sign up to our newsletters and we’ll keep you up to date with everything to do with INSIGHT.